Email this article to a friend
Early MRI response monitoring of patients with advanced hepatocellular carcinoma under treatment with the multikinase inhibitor sorafenib
-
* Corresponding author: Michael Bitzer michael.bitzer@uni-tuebingen.de
BMC Cancer 2009, 9:208 doi:10.1186/1471-2407-9-208